How Not to Choose Which Science Is Worth Funding
Or why we should choose what to fund at random.
Or why we should choose what to fund at random.
We have developed an analysis pipeline to facilitate real-time mutation tracking in SARS-CoV-2, focusing initially on the Spike (S) protein because it mediates infection of human cells and is the target of most vaccine strategies and antibody-based therapeutics.
Anna Severin explains how her team used machine learning to try to assess the quality of thousands of reviewers' reports.
Researchers will have to publicly report the results of many more clinical trials under new government rules announced Friday.
In this blog, I will examine the hypothesis that blogs are, on average, of higher quality than journal articles.
Ultimately, the power to enforce change resides in the hands of scientists.
The long read: For decades it has been the dominant metaphor in neuroscience. But could this idea have been leading us astray all along?
A simple framework can help you to identify 'likeable freeloaders' and 'misaligned partners' - and to self-assess.
The interests of the legacy publishers cannot co-exist with the ideals of the Open Access movement.
American pigs are raised on a liberal diet of antibiotics, fueling the rise of resistant germs. Danish pork producers are proving there's a better way.
The research conducted using federal funds is driven - and distorted - by the academic publishing model.
It takes an average of 15 clicks for a researcher to find and access a journal article. This time could be much better spent
Mathematician and educator Freeman A. Hrabowski III talks about the importance of the humanities, culture change in academia, and much more. He has led groundbreaking efforts to increase diversity in science, technology, engineering, and mathematics (STEM) fields throughout his career. As president of the University of Maryland, Baltimore County (UMBC) for three decades, Hrabowski transformed a regional commuter school into a top-tier research university.
Policymakers are moving forward with plans to turn our genetic information into potentially lucrative data. Drawing on recent Freedom of Information disclosures, Edward Hockings and Lewis Coyne ask whether we can trust our institutions with our genomes.
The COVID-19 pandemic is significantly impacting universities and higher education institutions, reducing budgets and presenting new design challenges.
With almost 70% of the country fully vaccinated, Israel has seen a life after COVID-19. But now infections are on the rise. What's going on? Will a third jab help?
Just another talking club or a genuine attempt to give science more weight in policy matters of global importance? Time will tell whether the United Nations' newly created scientific advisory board, whose members were announced last week, will indeed influence the business of international policy-making in practice.
ResearchGate, the largest professional network for researchers, and Wiley, a global leader in research and education, today announced a cooperation agreement to explore ways in which Wiley and ResearchGate can collaborate to better support the needs of researchers through ResearchGate’s collaboration platform.
Academics often complain about how long it takes for a paper to undergo peer reveiw. A publication reveals several striking observations based on these experiences.
Complex, diverse rationales require nuanced policies: evidence suggests a need for increased attention to career planning among students, their mentors, graduate schools, and funders
With the aim of maintaining the competitiveness of Swiss research, the SNSF is launching a new career funding scheme at assistant professor level.
Therapies and vaccines will come, but not for many months. Until then, politicians will have to work on the basics
Several cases of renowned scientists being offered large sums of money by institutions in authoritarian countries - such as Saudi Arabia - have been exposed by EL PAIS.
John Ioannidis is perhaps best known for a 2005 paper “Why Most Published Research Findings Are False.” One of the most highly cited researchers in the world, Ioannidis, a professor at Stanford, has built a career in the field of meta-research.